Dr. Tayebi is a physician-scientist who has had extensive training and experience on four different continents and countries including Iran, Singapore, Germany, Canada, and now the United States. After graduating from medical school in Iran, she went on to serve professionally in the human genetics field because of her enthusiasm for hereditary disorders. Thereafter she decided to continue her studies in the human genetics field in Singapore, and most of her research centered on GWAS. She applied for a PhD position at Max Planck Institute for molecular genetics in Berlin, and joined the research group of Prof. Stefan Mundlos. As a PhD candidate, she was able to find the pathogenic variants in a novel gene called ZAK in WES data. After that, a mouse model using CRISPR/Cas9 was generated to address the possible correlation between limb phenotype and Zak gene. Her first postdoctoral training at Hospital for Sick Children in Toronto was focused on hypertrophic cardiomyopathy along with hiPSC-cardiomyocyte disease modeling using CRISPR/Cas9. During her second postdoctoral position at Washington University with Dr. Gurnett’s group in St. Louis, she did a lot of research along with publications in Glut1DS. She joined Dr. Cruchaga lab in May 2023, and works with hiPSC derived neurons from patients with AD, controls and is involved in analyzing RNA sequencing data.